Bleeding News and Research

RSS

Daiichi Sankyo initiates Phase III trial of edoxaban in reducing recurrent VTE complications

Daiichi Sankyo Company, Limited, announced today that it has initiated a new large-scale pivotal Phase III trial for edoxaban, its investigational oral Factor Xa inhibitor. This new study, called HOKUSAI (pronounced hoe·koo·sigh) VTE, is evaluating the safety and efficacy of edoxaban in reducing recurrent venous thromboembolic (VTE) complications in patients with deep vein thrombosis (DVT) and/or pulmonary embolism (PE).

3 Feb 2010

Xiaflex receives FDA approval for treatment of Dupuytren's contracture

The U.S. Food and Drug Administration today approved Xiaflex (collagenase clostridium histolyticum) as the first drug to treat a progressive hand disease known as Dupuytren's contracture, which can affect a person's ability to straighten and properly use their fingers.

2 Feb 2010

Halt Medical commences enrollment in uterine fibroid study

The Wall Street Journal, CBS, and other popular news outlets have recently featured headline stories about a clinical study that is recruiting patients suffering with uterine fibroids. "We're not at all surprised by the attention this study is getting from the media," said Russ DeLonzor, President and Chief Operating Officer of Halt Medical, Inc., a medical technology company headquartered near San Francisco.

2 Feb 2010

Cardiac catheterization: A groundbreaking tool in the field of cardiology

Cardiac catheterizations have been a groundbreaking tool in the field of cardiology. This procedure offers a minimally invasive means for obtaining important information about the heart and its blood vessels, while also providing a less invasive treatment for certain heart conditions.

2 Feb 2010

Serious liver disorder associated with use of HIV drug, FDA warns

The U.S. Food and Drug Administration today announced that non-cirrhotic portal hypertension, a rare, but serious, liver disorder, has been reported in some HIV patients taking Videx/Videx EC (didanosine).

2 Feb 2010

Ipsen reports consolidated group sales of €1,032.8M for 2009

Ipsen reported today its sales for the fourth quarter and full year 2009.

1 Feb 2010

Salient Surgical Technologies, Exeter Hospital and Moffitt Cancer Center donate medical supplies to Haiti

Salient Surgical Technologies of Portsmouth, New Hampshire, has partnered with Exeter Hospital in Exeter, New Hampshire and Moffitt Cancer Center in Tampa, Florida, to donate equipment and supplies for a mission to aid victims of the January 12 earthquake in Haiti.

30 Jan 2010

Access Scientific's PICC WAND receives FDA clearance

Access Scientific has received FDA clearance for The PICC WANDTM, which enables clinicians to insert a peelable sheath for PICC or Midline catheter placement using the new Accelerated Seldinger Technique (AST). The PICC WAND is an all-in-one safety introducer that addresses the over-wire vascular access market, valued at more than $1 billion, by providing faster, safer and simpler vascular access.

27 Jan 2010

Discovery challenges understanding of blood cell development

University of Utah researchers led an international team of scientists that is the first to report on the previously undescribed ability of platelets to reproduce themselves in the circulation. Their revolutionary findings were published online Jan. 19, 2010, in the journal Blood.

27 Jan 2010

Ablation therapy better than drug therapy for heart rhythm disorder

Treating a common heart rhythm disorder by burning heart tissue with a catheter works dramatically better than drug treatments, according to a landmark study published in the Jan. 27 issue of the Journal of the American Medical Association (JAMA).

27 Jan 2010

Twenty nations meet in Montreal to discuss Haiti recovery; Haitian officials increase Port-Au-Prince death toll estimate

Officials from 20 countries are meeting in Montreal, Canada, Monday "to discuss long-term reconstruction and arrangements for a donor conference to be held in March," the U.N. said, Bloomberg reports (Gaouette/Craze, 1/25). "U.S. Secretary of State Hillary Clinton, Canadian Prime Minister Stephen Harper, French Foreign Minister Bernard Kouchner and others will examine eventual debt forgiveness and" a strategy for rebuilding Haiti at the one-day gathering, according to Reuters (Palmer, 1/25).

27 Jan 2010

Biogen Idec and Swedish Orphan Biovitrum commence dosing in rFIXFc Phase I/IIa trial for hemophilia B

Biogen Idec and Swedish Orphan Biovitrum today announced that the first patient was dosed in a registrational, open-label, multicenter trial designed to evaluate the safety, pharmacokinetics and efficacy of the companies’ long-acting, recombinant Factor IX Fc fusion protein (rFIXFc) in hemophilia B patients.

25 Jan 2010

OrbusNeich's clinical data demonstrates the benefits of Genous Bio-engineered R stent

OrbusNeich announced that clinical data presented today at Asia PCR/Singapore LIVE 2010 demonstrated the benefits of the Genous Bio-engineered R stent in the treatment of two challenging patient subsets.

24 Jan 2010

Final data from Poniard Pharmaceuticals' randomized Phase 2 trial of picoplatin announced

Poniard Pharmaceuticals, Inc., a biopharmaceutical company focused on innovative oncology therapies, today announced final data from a randomized, controlled Phase 2 trial of picoplatin in metastatic colorectal cancer (CRC) patients.

24 Jan 2010

Interventional cardiologist accesses coronary arteries through radial artery on the inside of wrist

In an innovative new procedure, interventional cardiologist Ramesh Mazhari, MD, is one of only a few in the Washington, DC, region to access the coronary arteries through the radial artery on the inside of the wrist.

23 Jan 2010

Ipsen and Inspiration Biopharmaceuticals form strategic partnership

Celtic Pharmaceutical Holdings L.P. ("Celtic Pharma") today announced the formation of a strategic partnership between Ipsen and Inspiration Biopharmaceuticals ("Inspiration") to create a world leading hemophilia franchise, an important milestone for the Celtic Pharma portfolio.

21 Jan 2010

Fourth-quarter and fiscal year 2009 results announced by Somanetics

Somanetics Corporation today reported financial results for the fourth fiscal quarter and year ended November 30, 2009.

21 Jan 2010

FDA approves Thoratec's HeartMate II LVAS for DT

Thoratec Corporation, a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, said today that it has received FDA approval of its PMA (Pre-Market Approval) supplement, allowing the use of its HeartMate II LVAS (Left Ventricular Assist System) for Destination Therapy (DT).

21 Jan 2010

Ipsen enters into partnership agreement with Inspiration Biopharmaceuticals

Ipsen and Inspiration Biopharmaceuticals, Inc. (Inspiration) today announced that they have entered into a partnership to create a world leading hemophilia franchise. The partnership is designed to leverage combined expertise and resources to advance a broad portfolio of recombinant proteins, which address all major hemophilia disorders in a unique way by focusing on two significant unmet needs: wider access to treatment with coagulation factors and treatment for inhibitor complications.

21 Jan 2010

Attaching cartilage to polydioxanone plates facilitates corrective surgery on nasal septum

Attaching cartilage to plates made of the resorbable material polydioxanone appears to facilitate corrective surgery on the nasal septum, the thin cartilage separating the two airways, according to a report in the January/February issue of Archives of Facial Plastic Surgery, one of the JAMA/Archives journals.

19 Jan 2010

Bleeding News and Research

Daiichi Sankyo initiates Phase III trial of edoxaban in reducing recurrent VTE complications

Xiaflex receives FDA approval for treatment of Dupuytren's contracture

Halt Medical commences enrollment in uterine fibroid study

Cardiac catheterization: A groundbreaking tool in the field of cardiology

Serious liver disorder associated with use of HIV drug, FDA warns

Ipsen reports consolidated group sales of €1,032.8M for 2009

Salient Surgical Technologies, Exeter Hospital and Moffitt Cancer Center donate medical supplies to Haiti

Access Scientific's PICC WAND receives FDA clearance

Discovery challenges understanding of blood cell development

Ablation therapy better than drug therapy for heart rhythm disorder

Twenty nations meet in Montreal to discuss Haiti recovery; Haitian officials increase Port-Au-Prince death toll estimate

Biogen Idec and Swedish Orphan Biovitrum commence dosing in rFIXFc Phase I/IIa trial for hemophilia B

OrbusNeich's clinical data demonstrates the benefits of Genous Bio-engineered R stent

Final data from Poniard Pharmaceuticals' randomized Phase 2 trial of picoplatin announced

Interventional cardiologist accesses coronary arteries through radial artery on the inside of wrist

Ipsen and Inspiration Biopharmaceuticals form strategic partnership

Fourth-quarter and fiscal year 2009 results announced by Somanetics

FDA approves Thoratec's HeartMate II LVAS for DT

Ipsen enters into partnership agreement with Inspiration Biopharmaceuticals

Attaching cartilage to polydioxanone plates facilitates corrective surgery on nasal septum

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News